{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:37:39Z","timestamp":1791254259737,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM133421"],"award-info":[{"award-number":["R35GM133421"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA059194"],"award-info":[{"award-number":["R01DA059194"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA052169"],"award-info":[{"award-number":["R01DA052169"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA061433"],"award-info":[{"award-number":["R01DA061433"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH128217"],"award-info":[{"award-number":["R01MH128217"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH121848"],"award-info":[{"award-number":["R01MH121848"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH137047"],"award-info":[{"award-number":["R01MH137047"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH136708"],"award-info":[{"award-number":["R01MH136708"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH133849"],"award-info":[{"award-number":["R01MH133849"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tips.2025.07.017","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T04:11:06Z","timestamp":1756354266000},"page":"1224-1240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The ABCs of psychedelics: a preclinical roadmap for drug discovery"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-1667","authenticated-orcid":false,"given":"Alex C.","family":"Kwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mantsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.07.017_bb0005","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2025.07.017_bb0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tips.2025.07.017_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.tips.2025.07.017_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled Phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2025.07.017_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1476-5381.1959.tb00933.x","article-title":"The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation","volume":"14","author":"Vane","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.tips.2025.07.017_bb0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1749-6632.1957.tb40738.x","article-title":"A review of the clinical effects of psychotomimetic agents","volume":"66","author":"Osmond","year":"1957","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2025.07.017_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012412","article-title":"Psychometric evaluation of the altered states of consciousness rating scale (OAV)","volume":"5","author":"Studerus","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2025.07.017_bb0040","series-title":"PIHKAL: A Chemical Love Story","author":"Shulgin","year":"1990"},{"key":"10.1016\/j.tips.2025.07.017_bb0045","series-title":"TiHKAL: The Continuation","author":"Shulgin","year":"2002"},{"key":"10.1016\/j.tips.2025.07.017_bb0050","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tips.2025.07.017_bb0060","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acschemneuro.2c00597","article-title":"Pharmacological mechanism of the non-hallucinogenic 5-HT(2A) agonist Ariadne and analogs","volume":"14","author":"Cunningham","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0070","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.017_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","article-title":"Bespoke library docking for 5-HT(2A) receptor agonists with antidepressant activity","volume":"610","author":"Kaplan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0085","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.cell.2021.03.043","article-title":"Psychedelic-inspired drug discovery using an engineered biosensor","volume":"184","author":"Dong","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.07.017_bb0090","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","article-title":"Identification of 5-HT(2A) receptor signaling pathways associated with psychedelic potential","volume":"14","author":"Wallach","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.017_bb0095","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acsptsci.3c00192","article-title":"Comparative pharmacological effects of lisuride and lysergic acid diethylamide revisited","volume":"7","author":"Glatfelter","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tips.2025.07.017_bb0100","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.tips.2025.07.017_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyac075","article-title":"Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants","volume":"26","author":"Becker","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112203","article-title":"A non-hallucinogenic LSD analog with therapeutic potential for mood disorders","volume":"42","author":"Lewis","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.07.017_bb0115","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1523\/JNEUROSCI.1384-23.2023","article-title":"Beyond the 5-HT(2A) receptor: classic and nonclassic targets in psychedelic drug action","volume":"43","author":"Cameron","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14740338.2023.2248883","article-title":"Serotonin 5-HT(2B) receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents","volume":"22","author":"McIntyre","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.tips.2025.07.017_bb0125","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1021\/acschemneuro.4c00513","article-title":"Serotonin 1A receptors modulate serotonin 2A receptor-mediated behavioral effects of 5-methoxy-N,N-dimethyltryptamine analogs in mice","volume":"15","author":"Glatfelter","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41586-024-07403-2","article-title":"Structural pharmacology and therapeutic potential of 5-methoxytryptamines","volume":"630","author":"Warren","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ijnp\/pyy047","article-title":"Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics","volume":"21","author":"Luethi","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0140","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1039\/D3CB00114H","article-title":"Protein conformational ensembles in function: roles and mechanisms","volume":"4","author":"Nussinov","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.tips.2025.07.017_bb0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.07.017_bb0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bcp.15887","article-title":"Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants","volume":"90","author":"Holze","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0155","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00702-017-1749-0","article-title":"Functional activation of Galpha(q) coupled to 5-HT(2A) receptor and M(1) muscarinic acetylcholine receptor in postmortem human cortical membranes","volume":"124","author":"Odagaki","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tips.2025.07.017_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175642","article-title":"Mini-G proteins: novel tools for studying GPCRs in their active conformation","volume":"12","author":"Nehme","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2025.07.017_bb0165","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tips.2025.07.017_bb0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","article-title":"TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome","volume":"16","author":"Olsen","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2025.07.017_bb0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.74101","article-title":"Effector membrane translocation biosensors reveal G protein and betaarrestin coupling profiles of 100 therapeutically relevant GPCRs","volume":"11","author":"Avet","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.07.017_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12178","article-title":"Monitoring G protein-coupled receptor and beta-arrestin trafficking in live cells using enhanced bystander BRET","volume":"7","author":"Namkung","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.017_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aab4068","article-title":"Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors","volume":"8","author":"Masuho","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2025.07.017_bb0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/bph.15962","article-title":"Advancements in G protein-coupled receptor biosensors to study GPCR-G protein coupling","volume":"180","author":"Olsen","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0195","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2025.07.017_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114251","article-title":"Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT(2A)R through simultaneous use of beta-arrestin 2 and miniGalpha(q) bioassays","volume":"182","author":"Pottie","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0205","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1007\/s00213-014-3557-7","article-title":"Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes","volume":"231","author":"Blough","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pr.118.016790","article-title":"Biased receptor signaling in drug discovery","volume":"71","author":"Kenakin","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2025.07.017_bb0215","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1111\/bph.15811","article-title":"Community guidelines for GPCR ligand bias: IUPHAR review 32","volume":"179","author":"Kolb","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10842","article-title":"The role of kinetic context in apparent biased agonism at GPCRs","volume":"7","author":"Klein Herenbrink","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.017_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adi4747","article-title":"Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling","volume":"17","author":"Wright","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tips.2025.07.017_bb0230","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0235","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0240","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cpt.2821","article-title":"Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants","volume":"113","author":"Holze","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2025.07.017_bb0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tips.2025.07.017_bb0250","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tips.2025.07.017_bb0255","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/acschemneuro.4c00058","article-title":"RE104: synthesis and activity of a novel serotonergic psychedelic prodrug of 4-hydroxy-N,N-diisopropyltryptamine","volume":"15","author":"Bryson","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0265","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41467-025-56850-6","article-title":"Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression","volume":"16","author":"Aboharb","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.017_bb0270","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.tips.2025.07.017_bb0275","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.107.130625","article-title":"Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys","volume":"324","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.07.017_bb0280","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neubiorev.2003.11.012","article-title":"LSD, 5-HT (serotonin), and the evolution of a behavioral assay","volume":"27","author":"Appel","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2025.07.017_bb0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-009-1718-x","article-title":"LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor","volume":"208","author":"Halberstadt","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0290","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","article-title":"Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers","volume":"37","author":"Quednow","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0295","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2025.07.017_bb0300","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41467-019-13809-8","article-title":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines","volume":"11","author":"Ali","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.017_bb0305","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1021\/acsptsci.2c00177","article-title":"Structure-activity relationships for psilocybin, baeocystin, aeruginascin, and related analogues to produce pharmacological effects in mice","volume":"5","author":"Glatfelter","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tips.2025.07.017_bb0310","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41386-023-01572-w","article-title":"5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice","volume":"48","author":"Jefferson","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0315","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41593-020-00734-z","article-title":"Quantifying behavior to understand the brain","volume":"23","author":"Pereira","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0320","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41593-024-01649-9","article-title":"Simple behavioral analysis (SimBA) as a platform for explainable machine learning in behavioral neuroscience","volume":"27","author":"Goodwin","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0325","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41592-024-02200-1","article-title":"A-SOiD, an active-learning platform for expert-guided, data-efficient discovery of behavior","volume":"21","author":"Tillmann","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tips.2025.07.017_bb0330","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41593-020-00706-3","article-title":"Revealing the structure of pharmacobehavioral space through motion sequencing","volume":"23","author":"Wiltschko","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0335","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/C6MD00128A","article-title":"In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents","volume":"7","author":"Shao","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.tips.2025.07.017_bb0340","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41386-023-01545-z","article-title":"Acute psilocybin enhances cognitive flexibility in rats","volume":"48","author":"Torrado Pacheco","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0345","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/s41380-024-02575-9","article-title":"Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms","volume":"29","author":"Conn","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tips.2025.07.017_bb0350","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41586-025-08813-6","article-title":"Psilocybin\u2019s lasting action requires pyramidal cell types and 5-HT2A receptors","volume":"642","author":"Shao","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0355","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.adl0666","article-title":"Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states","volume":"386","author":"Muir","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.017_bb0360","article-title":"Behavioural investigations of psilocybin in animals 1962-2021: a scoping review","author":"Shore","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2025.07.017_bb0365","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41386-023-01625-0","article-title":"Advancing preclinical chronic stress models to promote therapeutic discovery for human stress disorders","volume":"49","author":"Gyles","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0370","article-title":"A multi-institutional investigation of psilocybin\u2019s effects on mouse behavior","author":"Lu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2025.07.017_bb0375","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1021\/acschemneuro.4c00279","article-title":"Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors","volume":"15","author":"Woodburn","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110280","article-title":"Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner","volume":"266","author":"Farinha-Ferreira","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0385","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0269881120959614","article-title":"Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin","volume":"35","author":"Jefsen","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresprot.2005.09.002","article-title":"Learned helplessness: validity and reliability of depressive-like states in mice","volume":"16","author":"Chourbaji","year":"2005","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.tips.2025.07.017_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2019.07.007","article-title":"Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response","volume":"105","author":"Aleksandrova","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tips.2025.07.017_bb0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41583-024-00876-0","article-title":"Structural neural plasticity evoked by rapid-acting antidepressant interventions","volume":"26","author":"Liao","year":"2025","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0405","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2025.07.017_bb0410","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.07.017_bb0415","article-title":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","volume":"14","author":"Schmidt","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.07.017_bb0420","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408440801981981","article-title":"Enhancing and regulating neurite outgrowth","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tips.2025.07.017_bb0425","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1667\/RR2036.1","article-title":"Serum serotonin levels determine the magnitude and type of bystander effects in medium transfer experiments","volume":"174","author":"Mothersill","year":"2010","journal-title":"Radiat. Res."},{"key":"10.1016\/j.tips.2025.07.017_bb0430","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.07.017_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109836","article-title":"Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice","volume":"37","author":"de la Fuente Revenga","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.07.017_bb0440","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41380-021-01159-1","article-title":"An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress","volume":"26","author":"Lu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tips.2025.07.017_bb0445","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.07.017_bb0450","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0455","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschemneuro.2c00637","article-title":"Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin","volume":"14","author":"Davoudian","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0460","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41386-023-01613-4","article-title":"UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice","volume":"48","author":"Rijsketic","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2025.07.017_bb0465","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ynstr.2018.05.004","article-title":"What does the Fos say? Using Fos-based approaches to understand the contribution of stress to substance use disorders","volume":"9","author":"McReynolds","year":"2018","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.tips.2025.07.017_bb0470","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.07.017_bb0475","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/s41592-024-02375-7","article-title":"Rapid, biochemical tagging of cellular activity history in vivo","volume":"21","author":"Zhang","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tips.2025.07.017_bb0480","article-title":"Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression","author":"Liao","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2025.07.017_bb0485","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","article-title":"5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines","volume":"14","author":"Cameron","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0490","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1038\/s41380-023-02280-z","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","volume":"28","author":"Kiilerich","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tips.2025.07.017_bb0495","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.neuron.2024.08.016","article-title":"Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI","volume":"112","author":"Tiwari","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.07.017_bb0500","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1523\/JNEUROSCI.6377-11.2012","article-title":"Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs","volume":"32","author":"Wood","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2025.07.017_bb0505","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41586-020-2731-9","article-title":"Deep posteromedial cortical rhythm in dissociation","volume":"586","author":"Vesuna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0510","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1016\/j.celrep.2019.02.104","article-title":"A hallucinogenic serotonin-2A receptor agonist reduces visual response gain and alters temporal dynamics in mouse V1","volume":"26","author":"Michaiel","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.07.017_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4740","article-title":"Striatal dopamine mediates hallucination-like perception in mice","volume":"372","author":"Schmack","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.017_bb0520","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.07.017_bb0525","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1074\/jbc.M114.548131","article-title":"Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR)","volume":"289","author":"Strachan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2025.07.017_bb0530","doi-asserted-by":"crossref","first-page":"C583","DOI":"10.1152\/ajpcell.00464.2021","article-title":"Recent progress in assays for GPCR drug discovery","volume":"323","author":"Guo","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.tips.2025.07.017_bb0535","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2010.00863.x","article-title":"Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays","volume":"161","author":"Charlton","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0540","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1124\/mol.118.112573","article-title":"Equilibrium assays are required to accurately characterize the activity profiles of drugs modulating Gq-protein-coupled receptors","volume":"94","author":"Bdioui","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0545","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","author":"UniProt","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tips.2025.07.017_bb0550","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0026-895X(25)09924-9","article-title":"Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines","volume":"45","author":"Johnson","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2025.07.017_bb0555","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1124\/dmd.108.024745","article-title":"Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport","volume":"37","author":"Syvanen","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tips.2025.07.017_bb0560","doi-asserted-by":"crossref","first-page":"21264","DOI":"10.1021\/acs.jmedchem.4c02174","article-title":"Potent and selective human 5-HT(2B) serotonin receptor antagonists: 4'-cyano-(N)-methanocarba-adenosines by synthetic serendipity","volume":"67","author":"Tosh","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2025.07.017_bb0565","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/360161a0","article-title":"A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors","volume":"360","author":"Oksenberg","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.07.017_bb0570","article-title":"Simultaneous 5-HT1BR agonist\/5-HT6R antagonist action as a potential treatment of Parkinson\u2019s disease and its comorbidities","volume":"392","author":"Zajdel","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2025.07.017_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk4855","article-title":"Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT1eR and 5-HT1FR","volume":"10","author":"Zilberg","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2025.07.017_bb0580","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T16:54:43Z","timestamp":1765126483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":116,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0165614725001609"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.07.017","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ABCs of psychedelics: a preclinical roadmap for drug discovery","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}